Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report report published on Friday morning,Benzinga reports. The brokerage currently has a $10.00 price objective on the medical research company’s stock. A number of other equities research analysts have also issued reports on the company. StockNews.com began […]
More Stories
HICL Infrastructure (LON:HICL) Reaches New 12-Month Low – Here’s Why
HICL Infrastructure PLC (LON:HICL – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday ....
Comstock Resources (NYSE:CRK) Reaches New 1-Year High – Here’s Why
Comstock Resources, Inc. (NYSE:CRK – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday ....
Atlanta Braves (NASDAQ:BATRK) Hits New 12-Month Low – What’s Next?
Shares of Atlanta Braves Holdings, Inc. (NASDAQ:BATRK – Get Free Report) hit a new 52-week low during trading on Wednesday...
East West Petroleum (CVE:EW) Stock Price Up 28.6% – Should You Buy?
East West Petroleum Corp. (CVE:EW – Get Free Report)’s stock price traded up 28.6% on Wednesday . The stock traded...
Essent Group (NYSE:ESNT) Given New $72.00 Price Target at Keefe, Bruyette & Woods
Essent Group (NYSE:ESNT – Get Free Report) had its price target dropped by equities researchers at Keefe, Bruyette & Woods...
Biden Confirms He’s Considering Preemptive Pardons
By Zachary Stieber President Joe Biden in a Jan. 5 interview confirmed that he is considering whether to issue preemptive...